tiprankstipranks
Circassia Pharmaceuticals PLC (CSSPF)
OTHER OTC:CSSPF
US Market
CSSPF
Circassia Pharmaceuticals
RESEARCH TOOLSreports

Circassia Pharmaceuticals (CSSPF) Balance Sheet

9 Followers

Circassia Pharmaceuticals Balance Sheet

Circassia Pharmaceuticals's total assets for Q4 2025 were £76.20M, an increase of 7.32% from the previous quarter. CSSPF total liabilities were £8.60M for the fiscal quarter, a 30.30% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Assets
£ 76.20M£ 68.40M£ 91.50M£ 98.50M£ 86.40M
Total Liabilities
£ 8.60M£ 8.90M£ 7.70M£ 16.60M£ 19.60M
Total Equity Gross Minority
£ 67.60M£ 59.50M£ 83.80M£ 81.90M£ 66.80M
Other Metrics
Currency in GBP

Circassia Pharmaceuticals Debt to Assets